NCT06378190
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06378190
Title Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology (TranspoCART19)
Acronym TranspoCART19
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Instituto de Investigacion Biomedica de Salamanca
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital Clínic NOT_YET_RECRUITING Barcelona Barcelona Spain Details
Institut Català d'Oncologia Hospital RECRUITING L'Hospitalet de Llobregat Barcelona Spain Details
Fundación Jiménez Díaz Hospital RECRUITING Madrid Madrid Spain Details
Virgen de la Arrixaca University Hospital RECRUITING El Palmar Mur Spain Details
Clínica Universidad de Navarra RECRUITING Pamplona Navarre 31008 Spain Details
University Hospital of Navarra RECRUITING Pamplona Navarre Spain Details
Salamanca University Health Care Complex RECRUITING Salamanca SALAMANCA 37007 Spain Details
Virgen del Rocio Hospital RECRUITING Seville Sevilla Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field